We are pleased to invite you to participate in the “NAC-AX Delphi Consensus Study”, an initiative aimed to define best practice and establishing international consensus recommendations for the management of the positive axilla in patients undergoing neoadjuvant chemotherapy.
This study aims to achieve international expert consensus (3 rounds) from breast oncology surgeons. Panellists must be from an OECD country to ensure the potential for achieving consensus. All contributors will be eligible for authorship on resulting publications.
To enrol and begin Round 1, panellists can click the link below:
https://forms.gle/xnvXDX5ZmuPf9MwU9
We greatly appreciate the expertise to help shape international consensus in this evolving field.
Kind regards,
Mr. James Lucocq, Mr. Kenneth Elder
On behalf of the NAC-AX Delphi Study Group
Edinburgh Breast Unit, UK
